THC Stock Analysis: Buy, Sell, or Hold?
THC - Tenet Healthcare Corporation New
$254.78
2.05 (0.81%)
▲
5d:
+9.25%
30d:
+33.25%
90d:
+43.85%
WAIT
LOW Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Oct 27, 2026
Smart Money Accumulation
None View Scanner →
Strength: 6.0/10
Get Alerted When THC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: THC is 16.2% above its trading range ($219.34). Market expects 2.7% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: THC is 16.2% above its trading range ($219.34). Market expects 2.7% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$241.33
Based on 0.6% avg growth
INTRINSIC VALUE TODAY
$149.84
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: THC is currently trading at $254.78, which is considered extended relative to its 30-day fair value range of $181.15 to $219.34. The stock's valuation (Forward PE: 12.5) is in line with its historical norms (11.5). At these levels, the market is pricing in 2.7% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, THC is showing sideways momentum. Immediate support is located at $191.26, while resistance sits at $262.68.
Market Sentiment: THC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, THC is showing sideways momentum. Immediate support is located at $191.26, while resistance sits at $262.68.
Market Sentiment: THC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$181.15 -
$219.34
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
48.6%
Protect Your Profits
THC is technically overbought (RSI 74). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+16.2% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($277.48)
- NEUTRAL: Market pricing in 2.7% annual earnings growth - fairly valued
- WARNING: Recommendation downgraded due to 16.2% overvaluation
Trading Range Analysis
30-Day Trading Range
$181.15 -
$219.34
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$191.26
Resistance Level
$262.68
Current Trend
Sideways
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.46
Wall Street Target
$277.48
(+8.9%)
Revenue Growth (YoY)
6.8%
Earnings Growth (YoY)
213.4%
Profit Margin
10.3%
Valuation Premium vs History
+2.7% premium
PE vs Historical
12.5 vs 11.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.7%
(market-implied from PE analysis)
1-Year Target
$261.66
(+3%)
2-Year Target
$268.72
(+6%)
3-Year Target
$275.98
(+8%)
3-Yr Target (if PE normalizes)
(PE: 12→12)
PE COMPRESSION
$254.71
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: -2.9%)
$387.48
(+52%)
Base:
(SPY PE: 12.5, Growth: -2.9%)
$232.90
(-9%)
Bear:
(PE: 10.6, Growth: -2.9%)
$197.97
(-22%)
📈
Valuation based on Current Earnings
Trailing PE: 9.77 | Current EPS (TTM): $25.87
Bull Case
$219.73
(-14%)
Analyst growth -21.0%, PE expands to 10.8
Base Case
$199.75
(-22%)
Market implied -21.0%, PE stable at 9.8
Bear Case
$171.86
(-33%)
Severe decline -20.0%, PE contracts to 8.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 02, 2026 2:11 PM ET
Data refreshes hourly during market hours. Next update: 3:11 PM
Data refreshes hourly during market hours. Next update: 3:11 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is THC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Paola M Arbour
SELL
6500 shares
2026-03-11
Thomas W Arnst
SELL
8000 shares
2026-03-09
R. Scott Ramsey
SELL
8017 shares
2026-03-02
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$453 | 47 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 46 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 47 HOLD |
|
CON
Concentra Group Holdings… |
STRONG BUY
8 analysts |
$33 | 61 BUY |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$133 | 53 HOLD |
Advanced THC Option Strategies
Professional options setups generated by AI based on today's THC price and gamma walls.
